Cited by 155Gastrointestinal motility and disordersProbiotics and Fermented FoodsGut microbiota and health

Efficacy of Probiotics in Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Controlled Trials

Nikfar, Shekoufeh, Rahimi, Roja, Rahimi, Fatemeh, Derakhshani, Saeed, Abdollahi, Mohammad·2008·Diseases of the Colon & Rectum

Abstract

PURPOSE: This study was designed to evaluate whether probiotics improve symptoms in patients with irritable bowel syndrome. METHODS: PubMed, Embase, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials were searched for studies that investigated the efficacy of probiotics in the management of irritable bowel syndrome. Clinical improvement was the key outcome of interest. Data were searched within the time period of 1966 through September 2007. RESULTS: Eight randomized, placebo-controlled, clinical trials met our criteria and were included in the analysis. Pooling of eight trials for the outcome of clinical improvement yielded a significant relative risk of 1.22 (95 percent confidence interval, 1.07-1.4; P = 0.0042). CONCLUSIONS: Probiotics may improve symptoms of irritable bowel syndrome and can be used as supplement to standard therapy.

Integrity signals

Registry

Crossref · 10.1007/s10350-008-9335-z

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nikfar, S., Rahimi, R., Rahimi, F., Derakhshani, S., & Abdollahi, M.
Affiliations
  • Ministry of Health and Medical Education (IR)
  • Pharmaceutical Sciences Research Center (IR)
Venue
Diseases of the Colon & Rectum
Published
2008-12
Volume
51
Issue
12
Pages
1775-1780
ISSN
0012-3706 (ISSN-L)
OpenAlex
W2110951839
Cited by
155
References
5
Citations by year
2024: 1 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 8 · 2018: 2 · 2017: 8 · 2016: 6 · 2015: 6 · 2014: 14 · 2013: 15 · 2012: 23
FWCI
3.27
Type
journal article
Language
en
Open access
closed
Locations
  • Diseases of the Colon & Rectum (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
probiotics, irritable bowel syndrome, symptom improvement, clinical improvement, dietary supplements, treatment efficacy
MeSH terms
Humans, Randomized Controlled Trials as Topic, Treatment Outcome, Probiotics, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review